Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

393 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP).
Arlet JB, Dimitri D, Pagnoux C, Boyer O, Maisonobe T, Authier FJ, Bloch-Queyrat C, Goulvestre C, Heshmati F, Atassi M, Guillevin L, Herson S, Benveniste O, Mouthon L. Arlet JB, et al. Neuromuscul Disord. 2006 May;16(5):334-6. doi: 10.1016/j.nmd.2006.03.002. Epub 2006 Apr 17. Neuromuscul Disord. 2006. PMID: 16616848
Renin-angiotensin system blockade promotes a cardio-renal protection in albuminuric homozygous sickle cell patients.
Haymann JP, Hammoudi N, Stankovic Stojanovic K, Galacteros F, Habibi A, Avellino V, Bartolucci P, Benzerara Y, Arlet JB, Djebbar M, Letavernier E, Grateau G, Tabibzadeh N, Girshovich A, Chaignon M, Girot R, Levy P, Lionnet F. Haymann JP, et al. Among authors: arlet jb. Br J Haematol. 2017 Dec;179(5):820-828. doi: 10.1111/bjh.14969. Epub 2017 Oct 19. Br J Haematol. 2017. PMID: 29048108 Free article. Clinical Trial.
Severe, non specific symptoms in non-typhoidal Salmonella infections in adult patients with sickle cell disease: a retrospective multicentre study.
Guery R, Habibi A, Arlet JB, Lionnet F, de Lastours V, Decousser JW, Mainardi JL, Razazi K, Baranes L, Bartolucci P, Godeau B, Galacteros F, Michel M, Mahevas M. Guery R, et al. Among authors: arlet jb. Infect Dis (Lond). 2018 Nov-Dec;50(11-12):822-830. doi: 10.1080/23744235.2018.1500706. Epub 2018 Oct 14. Infect Dis (Lond). 2018. PMID: 30317897
Prognosis of patients with sickle cell disease and COVID-19: a French experience.
Arlet JB, de Luna G, Khimoud D, Odièvre MH, de Montalembert M, Joseph L, Chantalat-Auger C, Flamarion E, Bartolucci P, Lionnet F, Monnier S, Guillaumat C, Santin A. Arlet JB, et al. Lancet Haematol. 2020 Sep;7(9):e632-e634. doi: 10.1016/S2352-3026(20)30204-0. Epub 2020 Jun 18. Lancet Haematol. 2020. PMID: 32563282 Free PMC article. No abstract available.
COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study.
Avouac J, Drumez E, Hachulla E, Seror R, Georgin-Lavialle S, El Mahou S, Pertuiset E, Pham T, Marotte H, Servettaz A, Domont F, Chazerain P, Devaux M, Claudepierre P, Langlois V, Mekinian A, Maria ATJ, Banneville B, Fautrel B, Pouchot J, Thomas T, Flipo RM, Richez C; FAI2R/SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors; FAIR/SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors. Avouac J, et al. Lancet Rheumatol. 2021 Jun;3(6):e419-e426. doi: 10.1016/S2665-9913(21)00059-X. Epub 2021 Mar 25. Lancet Rheumatol. 2021. PMID: 33786454 Free PMC article.
Risk factors for severe COVID-19 in hospitalized sickle cell disease patients: A study of 319 patients in France.
Arlet JB, Lionnet F, Khimoud D, Joseph L, de Montalembert M, Morisset S, Garou A, Cannas G, Cougoul P, Guitton C, Holvoet L, Odièvre MH, Cheminet G, Bartolucci P, Santin A, Bernit E, de Luna G; DREPANO COVID-19 Collaborative Group. Arlet JB, et al. Am J Hematol. 2022 Mar 1;97(3):E86-E91. doi: 10.1002/ajh.26432. Epub 2021 Dec 18. Am J Hematol. 2022. PMID: 34882837 Free PMC article. No abstract available.
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group.
Hermine O, Mariette X, Porcher R, Djossou F, Nguyen Y, Arlet JB, Savale L, Diehl JL, Georgin-Lavialle S, Cadranel J, Pialoux G, Lacombe K, Mekinian A, Gros H, Lescure X, Ghosn J, Coupez E, Grapin K, Rapp C, Michel M, Lecapitaine AL, Michot JM, Costedoat-Chalumeau N, Nguyen LBL, Semerano L, Raffi F, Aguillar C, Rouzaud C, Gottenberg JE, Hansmann Y, Bienvenu B, London J, Fantchou FS, Ackermann F, Gros A, Morel A, Gambier N, Sène D, Mégarbane B, Azoulay E, Bureau S, Dougados M, Emmerich J, Fartoukh M, Guidet B, Humbert M, Mahevas M, Pène F, Schlemmer F, Pourcher-Martinez V, Tibi A, Baron G, Perrodeau E, Baron S, Steg G, Yazdapanah Y, Simon T, Resche-Rigon M, Tharaux PL, Ravaud P. Hermine O, et al. Among authors: arlet jb. EClinicalMedicine. 2022 Mar 25;46:101362. doi: 10.1016/j.eclinm.2022.101362. eCollection 2022 Apr. EClinicalMedicine. 2022. PMID: 35350097 Free PMC article.
393 results